JP2009537512A - 特定の多糖類により胸焼け及び胃食道逆流病の症状を減少する方法 - Google Patents

特定の多糖類により胸焼け及び胃食道逆流病の症状を減少する方法 Download PDF

Info

Publication number
JP2009537512A
JP2009537512A JP2009510906A JP2009510906A JP2009537512A JP 2009537512 A JP2009537512 A JP 2009537512A JP 2009510906 A JP2009510906 A JP 2009510906A JP 2009510906 A JP2009510906 A JP 2009510906A JP 2009537512 A JP2009537512 A JP 2009537512A
Authority
JP
Japan
Prior art keywords
polysaccharide
preparation
acid
minutes
viscosity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009510906A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009537512A5 (cg-RX-API-DMAC7.html
Inventor
アンナ フェルブルッゲン,マリア
ティー. ケリー,カルビン
ジー. サダム,ブライネ
Original Assignee
フルタロム ネザーランズ ビー.ブイ.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by フルタロム ネザーランズ ビー.ブイ. filed Critical フルタロム ネザーランズ ビー.ブイ.
Publication of JP2009537512A publication Critical patent/JP2009537512A/ja
Publication of JP2009537512A5 publication Critical patent/JP2009537512A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731—Carrageenans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/732—Pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/738—Cross-linked polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Plant Substances (AREA)
JP2009510906A 2006-05-16 2007-05-16 特定の多糖類により胸焼け及び胃食道逆流病の症状を減少する方法 Pending JP2009537512A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06076056A EP1859786A1 (en) 2006-05-16 2006-05-16 A method to reduce the symptoms of heartburn and gastro-oesophageal reflux disease (GERD) by specific polysaccharides
US80631306P 2006-06-30 2006-06-30
PCT/NL2007/050224 WO2007133082A1 (en) 2006-05-16 2007-05-16 A method to reduce the symptoms of heartburn and gastro-oesophageal reflux disease (gerd) by specific polysaccharides

Publications (2)

Publication Number Publication Date
JP2009537512A true JP2009537512A (ja) 2009-10-29
JP2009537512A5 JP2009537512A5 (cg-RX-API-DMAC7.html) 2010-07-08

Family

ID=37806824

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009510906A Pending JP2009537512A (ja) 2006-05-16 2007-05-16 特定の多糖類により胸焼け及び胃食道逆流病の症状を減少する方法

Country Status (9)

Country Link
US (2) US20090252792A1 (cg-RX-API-DMAC7.html)
EP (2) EP1859786A1 (cg-RX-API-DMAC7.html)
JP (1) JP2009537512A (cg-RX-API-DMAC7.html)
KR (1) KR20090048393A (cg-RX-API-DMAC7.html)
AT (1) ATE514415T1 (cg-RX-API-DMAC7.html)
AU (1) AU2007250624B2 (cg-RX-API-DMAC7.html)
RU (1) RU2432167C2 (cg-RX-API-DMAC7.html)
TW (1) TWI402074B (cg-RX-API-DMAC7.html)
WO (1) WO2007133082A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019064980A (ja) * 2017-10-03 2019-04-25 小林製薬株式会社 逆流性食道炎改善剤

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090148530A1 (en) * 2007-12-08 2009-06-11 Jamie Koufman Method for prevention and treatment of reflux injury in the aerodigestive tract and laryngopharynx caused by pepsin
BRPI0919010A2 (pt) 2008-09-22 2015-08-18 Rubicon Res Private Ltd Composições exibindo trânsito retardado através do trato gastrointestinal.
WO2011135107A1 (es) 2010-04-26 2011-11-03 Angel Manuel Gago De Santos Composiciones para el alivio sintomático del dolor de estómago o reflujo gastroesofágico
ITRM20120041A1 (it) * 2012-02-08 2013-08-09 Dicofarm Spa "prodotto a base di glucomannano e chitosano utile per il trattamento del reflusso gastroesofageo"
ITRM20120084A1 (it) * 2012-03-07 2013-09-08 Aboca Spa Societa Agricola Miscela prebiotica.
US9452135B2 (en) 2012-03-20 2016-09-27 Particle Dynamics International, Llc Gelling agent-based dosage form
ITMI20130960A1 (it) * 2013-06-11 2014-12-12 Novintethical Pharma Sagl Composizioni a base di xiloglucano per il trattamento di disturbi gastrointestinali
IT201700091733A1 (it) * 2017-08-08 2019-02-08 Neilos S R L Composizione per somministrazione orale per uso nel trattamento terapeutico o preventivo dei disturbi o malattia da reflusso gastroesofageo
BR112021000917B1 (pt) 2018-07-23 2023-12-26 Nutragenom, Llc Solução de glucomanano e composição de geração de h2
CN111227156A (zh) * 2020-01-20 2020-06-05 陕西科技大学 一种抑制反酸的固体饮料及其制备方法
WO2022240224A1 (ko) * 2021-05-14 2022-11-17 한국식품연구원 젤란검을 유효성분으로 하는 장내 균총 개선용 조성물 및 이를 포함하는 대사성 질환 개선, 예방 또는 치료용 조성물
TWI777673B (zh) * 2021-07-16 2022-09-11 陳昭誠 由β-1-4-葡聚醣形成之纖維於製備用於治療或預防胃食道逆流之組成物之用途

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002544176A (ja) * 1999-05-05 2002-12-24 レキット ベンキサー ヘルスケア (ユーケイ) リミテッド 食道の疾患の治療のための組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3152319C2 (de) * 1980-09-03 1986-05-07 Kyosei Pharmaceutical Co., Ltd., Hokkaido Verwendung einer Lösung eines Salzes der Alginsäure zur Behandlung von Strahlenschäden und Ulcera
IL108583A (en) * 1994-02-07 1997-06-10 Yissum Res Dev Co Galactomannan emulsions and comestible products containing the same
GB9708773D0 (en) * 1997-04-30 1997-06-25 Reckitt & Colmann Prod Ltd Organic compositions
CA2206157C (en) * 1997-05-26 2000-06-13 Cheng, Peter Method of extraction of commercially valuable fractions of fenugreek
GB0005743D0 (en) * 2000-03-10 2000-05-03 Reckitt & Colmann Prod Ltd Pharmaceutical compositions including alginates
GB2384986B (en) * 2002-02-12 2004-01-07 Reckitt Benckiser Healthcare Compositions for the treatment of disorders of the upper gastrointestinal tract
DE602004004388T2 (de) * 2003-04-25 2007-11-29 Reckitt Benckiser Healthcare (Uk) Ltd., Slough Verdickbare zusammensetzungen
DK1638586T3 (da) * 2003-05-14 2008-06-23 Indus Biotech Pvt Ltd Synergistisk sammensætning til behandling af diabetes mellitus

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002544176A (ja) * 1999-05-05 2002-12-24 レキット ベンキサー ヘルスケア (ユーケイ) リミテッド 食道の疾患の治療のための組成物

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JPN6012042571; JOURNAL OF ETHNOPHARMACOLGY VOL.81, 2002, P.393-397 *
JPN6012042572; MODERN PHYSICIAN VOL.19, NO.12, 1999, P.1555-1558 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019064980A (ja) * 2017-10-03 2019-04-25 小林製薬株式会社 逆流性食道炎改善剤

Also Published As

Publication number Publication date
KR20090048393A (ko) 2009-05-13
ATE514415T1 (de) 2011-07-15
EP2026763A1 (en) 2009-02-25
TWI402074B (zh) 2013-07-21
RU2008149527A (ru) 2010-06-27
TW200812596A (en) 2008-03-16
US20120231078A1 (en) 2012-09-13
EP1859786A1 (en) 2007-11-28
EP2026763B1 (en) 2011-06-29
RU2432167C2 (ru) 2011-10-27
AU2007250624A1 (en) 2007-11-22
WO2007133082A1 (en) 2007-11-22
AU2007250624B2 (en) 2012-09-20
US20090252792A1 (en) 2009-10-08

Similar Documents

Publication Publication Date Title
AU2007250624B2 (en) A method to reduce the symptoms of heartburn and gastro-oesophageal reflux disease (GERD) by specific polysaccharides
US5023245A (en) Improved niacin formulation
US10758561B2 (en) Composition based on xyloglucan and proteins for the treatment of intestinal disorders
US20140356297A1 (en) Oral compositions for absorption of phosphorous compounds
BR112015016917B1 (pt) Forma de dosagem oral de retenção gástrica, e, uso de um sequestrante de ácido biliar
TW200930385A (en) Composition with active ingredient combination for the treatment of constipation
JP2003508467A (ja) アルファ−アミラーゼインヒビターと、腸からの「速効性糖類(fastsugars)」の吸収を減少させるために適する少なくとも一種類の生理学的に許容可能な化合物とを含む組成物
CN102844077A (zh) 一种用于中和胃酸的固体药物组合物
EP2812009B1 (en) Product comprising glucomannan and chitosan for the treatment of gastroesophageal reflux disease
CN112055594A (zh) 用于治疗口咽喉食管道的粘膜的液体组合物
US20070203242A1 (en) Method for treating gastric reflux
CN115364181A (zh) 一种保护及修复胃粘膜的口服液及其制备方法
CN117503794A (zh) 治疗胃食管反流的口服组合物
EP4059506A1 (en) Composition for the treatment of reflux esophagitis and related symptoms
EP3806907B1 (en) Composition for gastric and oesophageal diseases
CN105878263B (zh) 含有苹果酸氯波必利的药物组合物及其应用
WO2023026231A1 (en) Composition for the prevention and/or treatment of gastric and esophageal diseases
Porro et al. A controlled study of 20 mg famotidine nocte vs. 150 mg ranitidine nocte for the prevention of duodenal ulcer relapse
US20240366707A1 (en) Composition for the prevention and/or treatment of gastric and esophageal diseases
EP3242655B1 (en) Composition comprising tricalcium phosphate and gelatin for use in a method for the treatment of dyspepsia, acidic mouth and/or canker sores
JP2001501224A (ja) 胸焼けを予防及び治療するための方法及び組成物
WO2019030629A1 (en) COMPOSITION FOR ORAL ADMINISTRATION IN THERAPEUTIC OR PREVENTIVE TREATMENT OF DISORDERS OR DISEASE OF GASTROESOPHAGEAL REFLUX

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100513

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100519

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120816

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20121112

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20121119

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121217

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130205